Search - tctmd.com

Displaying 1 - 20 of 48

Sort: Relevancy | Date

News Daily News

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

L.A. McKeown

December 18, 2018

News Daily News

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

L.A. McKeown

December 17, 2018

News Daily News

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

L.A. McKeown

December 07, 2018

News Conference News VIVA 2018

No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy

L.A. McKeown

November 13, 2018

News Conference News VIVA 2018

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

L.A. McKeown

November 09, 2018

Attacking DVT With Drug-Device Combo Does Not Reduce Postthrombotic Syndrome

News Conference News VIVA 2018

VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease

L.A. McKeown

November 08, 2018

News Daily News

FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease

Caitlin E. Cox

October 05, 2018

News Industry News

Veryan Medical receives PMA approval for BioMimics 3D

October 05, 2018

Presentation TCT Abstracts Posters 2018

Occurrence of significant mirror lesions in the lower extremity arterial disease.

Presenter: Aleksandra Kolarczyk-Haczyk1

September 25, 2018

Presentation TCT 2018

PAD: Overview of Current Management Strategies - Can We Do Better?

Presenter: Wayne B. Batchelor, Aaron Horne, Jr., Foluso Fakorede

September 24, 2018

Presentation TCT 2018

How I Treat Femoral Vein Occlusions (With Case Reviews)

Presenter: Brian G. DeRubertis, Mahmood K. Razavi, Robert A. Lookstein

September 24, 2018

News Conference News TCT 2018

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

Todd Neale

September 24, 2018

News Conference News TCT 2018

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

Todd Neale

September 22, 2018

Presentation TCT 2018

DANCE: Two-Year Outcomes of Adventitial Dexamethasone Delivery During Femoropopliteal Revascularization

Presenter: Lindsay S. Machan, Craig M. Walker, Ehrin J. Armstrong

September 22, 2018

Presentation TCT 2018

EffPac-RCT: A Randomized Trial Evaluating a Drug-Coated Balloon in Superficial Femoral and Popliteal Arteries

Presenter: Lindsay S. Machan, Craig M. Walker, Marcus Thieme

September 22, 2018

Presentation TCT 2018

IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions

Presenter: William A. Gray

September 22, 2018

Presentation TCT 2018

Debate: Common Femoral Artery Disease Should be Treated Surgically!

Presenter: Gary M. Ansel, Ehrin J. Armstrong, Virendra I Patel

September 21, 2018

Presentation TCT 2018

Debate: Common Femoral Artery Lesions Can Be Treated with Endovascular Techniques!

Presenter: Gary M. Ansel, Ehrin J. Armstrong, George S Chrysant

September 21, 2018

Presentation TCT 2018

What is the Optimal Endovascular Treatment for SFA In-Stent Occlusions?

Presenter: Gary M. Ansel, Ehrin J. Armstrong, Craig M. Walker

September 21, 2018

Presentation TCT 2018

New Treatment Approaches for SFA Disease: Tacks, Shocks and Adventitial Drug Delivery

Presenter: Gary M. Ansel, Ehrin J. Armstrong

September 21, 2018

Advertisement

New Appropriate Use Criteria for Peripheral Artery Interventions: A Multisociety Collaboration

Two Trials Halted in Wake of Study Linking Paclitaxel-Coated Devices to Deaths in PAD

Signal of Late Deaths With Paclitaxel-Coated DCBs and Stents for PAD Warrants Urgent Review, Authors Say

No Gender Difference in Patency Rates 1 Year After DCB for PAD: ILLUMENATE Substudy

Now You See Them, Now You Don’t: Bioresorbable Devices Target Large-Bore Closures and PE Prevention

VERNACULAR: A Novel Venous Stent Shows Promise for Treatment of Iliofemoral Occlusive Disease

FDA Approves BioMimics 3D Stent for Femoropopliteal Artery Disease

Veryan Medical receives PMA approval for BioMimics 3D

Occurrence of significant mirror lesions in the lower extremity arterial disease.

PAD: Overview of Current Management Strategies - Can We Do Better?

How I Treat Femoral Vein Occlusions (With Case Reviews)

Eluvia Gains FDA Approval Just Days After IMPERIAL Results Released

IMPERIAL: Eluvia Tops Zilver PTX in Battle of DES in Femoropopliteal Disease

DANCE: Two-Year Outcomes of Adventitial Dexamethasone Delivery During Femoropopliteal Revascularization

EffPac-RCT: A Randomized Trial Evaluating a Drug-Coated Balloon in Superficial Femoral and Popliteal Arteries

IMPERIAL: A Randomized Trial of Drug-Eluting Stents for Treatment of Femoropopliteal Artery Lesions

Debate: Common Femoral Artery Disease Should be Treated Surgically!

Debate: Common Femoral Artery Lesions Can Be Treated with Endovascular Techniques!

What is the Optimal Endovascular Treatment for SFA In-Stent Occlusions?

New Treatment Approaches for SFA Disease: Tacks, Shocks and Adventitial Drug Delivery

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content